The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2015

Filed:

May. 24, 2011
Applicants:

Angela Mastaloudis, Holladay, UT (US);

Steve Wood, Santaquin, UT (US);

Richard Weindruch, Madison, WI (US);

Tomas Alberto Prolla, Madison, WI (US);

Jamie Louis Barger, Verona, WI (US);

Mark Bartlett, Orem, UT (US);

Scott B. Ferguson, Highland, UT (US);

Joseph Chang, Sandy, UT (US);

Inventors:

Angela Mastaloudis, Holladay, UT (US);

Steve Wood, Santaquin, UT (US);

Richard Weindruch, Madison, WI (US);

Tomas Alberto Prolla, Madison, WI (US);

Jamie Louis Barger, Verona, WI (US);

Mark Bartlett, Orem, UT (US);

Scott B. Ferguson, Highland, UT (US);

Joseph Chang, Sandy, UT (US);

Assignee:

NSE Products, Inc., Provo, UT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01); A23L 1/30 (2006.01); A61K 31/221 (2006.01); A61K 36/185 (2006.01); A61K 36/258 (2006.01); A61K 36/41 (2006.01); A61K 36/79 (2006.01); A61K 36/82 (2006.01); A61K 36/87 (2006.01); A61Q 19/08 (2006.01); A61K 8/97 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A23L 1/3002 (2013.01); A23V 2002/00 (2013.01); A61K 31/221 (2013.01); A61K 36/185 (2013.01); A61K 36/258 (2013.01); A61K 36/41 (2013.01); A61K 36/79 (2013.01); A61K 36/82 (2013.01); A61K 36/87 (2013.01); A61Q 19/08 (2013.01); A61K 8/97 (2013.01); A61K 2800/5922 (2013.01); A61K 2800/92 (2013.01);
Abstract

An oral formulation as described herein can comprise pomegranate extract, panax ginseng extract, and, where each is present in an amount effective to counteract and/or prevent effects of aging in a subject when administered to the subject. The effects of aging can include age-related changes in gene expression.


Find Patent Forward Citations

Loading…